| Trial ID: | L3648 |
| Source ID: | NCT01490112
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Surveillance Study of NovoRapid® for New Drug Re-examination
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Change in weight | Secondary: Fasting blood glucose (FBG)|HbA1c (glycosylated haemoglobin)|Adverse events: Serious and non-serious
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1239
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2005-01
|
| Completion Date: |
2006-06
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Seoul, 137-920, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01490112
|
